Testing susceptibility of fungi to fluconazole

  • M. Scheven


Internal Medicine Fluconazole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Polak A, Odds FC, Lüdin E, Scholer HJ Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model. Chemotherapy 1985, 31: 395–404.Google Scholar
  2. 2.
    Polak-Wyss A Die antimykotische Chemotherapie opportunistischer Pilzinfektionen. Habilitationsschrift, Albert-Ludwigs-Universitat, Freiburg 1989, p.28.Google Scholar
  3. 3.
    Troke PF, Andrews RJ, Pye GW, Richardson K Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Reviews of Infectious Diseases 1990, 12, Supplement 3: 276–280.Google Scholar
  4. 4.
    Kobayashi GS, Spitzer ED Testing of organisms for susceptibility to triazoles: is it justified? European Journal of Clinical Microbiology & Infectious Diseases 1989, 8: 387–389.Google Scholar
  5. 5.
    Cavalli-Sforza L Biometrie. Grundzüge biologischmedizinischer Statistik. Gustav-Fischer-Verlag, Jena, 1969, p.80–95.Google Scholar
  6. 6.
    Galgiani JN Susceptibility ofCandida albicans and other yeasts to fluconazole: relation between in vitro and in vivo studies. Reviews of Infectious Diseases 1990, 12, Supplement 3: 272–275.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1993

Authors and Affiliations

  • M. Scheven
    • 1
  1. 1.Medizinal-, Lebensmittel- und Veterinäruntersuchungsamt ThüringenHygieneinstitut GeraGeraGermany

Personalised recommendations